Briefings
Promotion of prescription medicines: International developments
Consumers International (CI) is currently undertaking a global
study on the promotion of prescription medecines in nine countries
across five continents.
This research briefing outlines the methodology used, as well as
presenting preliminary analysis on one of the project's key focus
areas: the regulation of gift-giving.
The final report will be expanded in scope to cover free samples, medical sales representatives, promotional materials and direct communication with patients. It will draw links between these issues and comment on compliance/enforcement issues.
An introduction to the campaign on drug marketing
Reports
Drugs, doctors and dinners
Could the expansion of the world’s largest drug companies into developing countries’ emerging markets constitute a serious public health risk?
This report catalogues irresponsible marketing practices and the lack of effective regulation in the developing world.
Branding the cure
Twenty drug companies based in Europe broke the Association of British Pharmaceutical Industry (ABPI) code a total of 972 times between 2002 and 2005.
This report looks at the drug marketing policies and practices of drug companies in Europe from a Corporate Social Responsibility perspective.
Company profiles
All drug companies have a responsibility to uphold the highest standards in their marketing practice.
However, the sheer size and influence of the largest companies (sales from the top 10 companies accounted for more than 40% of the total market in 2005) gives them an added responsibility.
Marketing Overdose will mainly focus on these companies. However, we will also support the work of national and local organisations that seek to improve the marketing of other companies.
